These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19412518)

  • 1. Correction: The value of periportal hyperintensity sign from gadobenate dimeglumine-enhanced hepatobiliary phase MRI for predicting clinical outcomes in patients with decompensated cirrhosis.
    Cong L; Deng Y; Cai S; Wang G; Zhao X; He J; Zhao S; Wang L
    Insights Imaging; 2024 May; 15(1):117. PubMed ID: 38735022
    [No Abstract]   [Full Text] [Related]  

  • 2. Illuminating the shades of hyper- to isointense lesions in hepatobiliary phase imaging.
    Ronot M
    Eur Radiol; 2024 Jul; ():. PubMed ID: 38981895
    [No Abstract]   [Full Text] [Related]  

  • 3. Differentiating Between an Atypical Hepatic Abscess and Tumor Metastasis Using Magnetic Resonance Imaging and Hepatobiliary Phase Imaging.
    Zhuo LY; Xing LH; Ma X; Zhang Y; Ma ZP; Yin XP; Wang JN
    Infect Drug Resist; 2021; 14():3263-3274. PubMed ID: 34429624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added value of hepatobiliary phase gadoxetic acid-enhanced MRI for diagnosing hepatocellular carcinoma in high-risk patients.
    Phongkitkarun S; Limsamutpetch K; Tannaphai P; Jatchavala J
    World J Gastroenterol; 2013 Dec; 19(45):8357-65. PubMed ID: 24363528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiating focal eosinophilic infiltration from metastasis in the liver with gadoxetic acid-enhanced magnetic resonance imaging.
    Lee MH; Kim SH; Kim H; Lee MW; Lee WJ
    Korean J Radiol; 2011; 12(4):439-49. PubMed ID: 21852904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The T2-shortening effect of gadolinium and the optimal conditions for maximizing the CNR for evaluating the biliary system: a phantom study.
    Lee MJ; Kim MJ; Yoon CS; Song SY; Park K; Kim WS
    Korean J Radiol; 2011; 12(3):358-64. PubMed ID: 21603295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gadoxetic acid (Gd-EOB-DTPA)-enhanced MRI versus gadobenate dimeglumine (Gd-BOPTA)-enhanced MRI for preoperatively detecting hepatocellular carcinoma: an initial experience.
    Park Y; Kim SH; Kim SH; Jeon YH; Lee J; Kim MJ; Choi D; Lee WJ; Kim H; Koo JH; Lim HK
    Korean J Radiol; 2010; 11(4):433-40. PubMed ID: 20592927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pictorial Review of Hepatobiliary Magnetic Resonance Imaging With Hepatocyte-Specific Contrast Agents: Uses, Findings, and Pitfalls of Gadoxetate Disodium and Gadobenate Dimeglumine.
    Scali EP; Walshe T; Tiwari HA; Harris AC; Chang SD
    Can Assoc Radiol J; 2017 Aug; 68(3):293-307. PubMed ID: 28583364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase.
    Jeong WK; Kim YK; Song KD; Choi D; Lim HK
    Clin Mol Hepatol; 2013 Dec; 19(4):360-6. PubMed ID: 24459639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypointense hepatic lesions depicted on gadobenate dimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: differentiation between benignancy and malignancy.
    Hwang HS; Kim SH; Jeon TY; Choi D; Lee WJ; Lim HK
    Korean J Radiol; 2009; 10(3):294-302. PubMed ID: 19412518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadobenate-dimeglumine-enhanced magnetic resonance imaging for hepatic lesions in children.
    Chavhan GB; Mann E; Kamath BM; Babyn PS
    Pediatr Radiol; 2014 Oct; 44(10):1266-74. PubMed ID: 24771094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
    Grazioli L; Morana G; Kirchin MA; Schneider G
    Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
    Jeon TY; Kim SH; Lee WJ; Lim HK
    Abdom Imaging; 2010 Jun; 35(3):337-45. PubMed ID: 19350315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglumine administration.
    Morana G; Grazioli L; Kirchin MA; Bondioni MP; Faccioli N; Guarise A; Schneider G
    Invest Radiol; 2011 Apr; 46(4):225-39. PubMed ID: 21102346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
    Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
    Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.